Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
Huimin Tao(Precision Research (United States)), Lian Li(Sun Yat-sen University), Yong‐Quan Xu(Tasly Holding Group (China)), Kun Meng(Hubei University of Arts and Science), Mingyu Liu(General Hospital of Guangzhou Military Command), Bin Ye(Southern University of Science and Technology), Yuan Wang(Sun Yat-sen University), Limin Zheng(Weifang University of Science and Technology), Shufeng Luo(Central South University)
Cited by 72
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Genome modeling and design across all domains of life with Evo 2
|bioRxiv (Cold Spring Harbor Laboratory)|2025|206
Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
|Journal of Clinical Investigation|2018|190
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|183